|
News Releases
Events
|
|
Newsroom | News
Releases Archives
December
08, 2008
CYPRESS BIOSCIENCE TO PRESENT AT OPPENHEIMER 19TH ANNUAL HEALTHCARE CONFERENCE
December
08, 2008
CYPRESS BIOSCIENCE TO PRESENT AT RBC CAPITAL MARKETS HEALTHCARE CONFERENCE
November
10, 2008
CYPRESS BIOSCIENCE ANNOUNCES THIRD QUARTER 2008 RESULTS
October
31, 2008
CYPRESS BIOSCIENCE TO PRESENT AT OPPENHEIMER 19TH ANNUAL HEALTHCARE CONFERENCE
October
24, 2008
CYPRESS BIOSCIENCE LAUNCHES TWO NEW PERSONALIZED MEDICINE SERVICES FOR RHEUMATOLOGISTS
October
20, 2008
FDA DEFERS FINAL ACTION ON MILNACIPRAN NEW DRUG APPLICATION
October
2, 2008
CYPRESS BIOSCIENCE TO PRESENT AT UPCOMING INVESTOR AND INDUSTRY CONFERENCES
September
18, 2008
CYPRESS BIOSCIENCE TO PRESENT AT UBS GLOBAL LIFE SCIENCES CONFERENCE
September
4, 2008
CYPRESS BIOSCIENCE TO PARTICIPATE IN CITI'S 3RD ANNUAL BIOTECH DAY
August
8, 2008
CYPRESS BIOSCIENCE ANNOUNCES SECOND QUARTER 2008 RESULTS
July
29, 2008
CYPRESS BIOSCIENCE TO PRESENT AT OPPENHEIMER SMALL & MID CAP CLINICAL & REGULATORY
CONFERENCE
June
23, 2008
CYPRESS BIOSCIENCE TO PRESENT AT JEFFERIES 2ND ANNUAL HEALTHCARE CONFERENCE
June
9, 2008
CYPRESS BIOSCIENCE TO PRESENT AT NEEDHAM & COMPANY BIOTECHNOLOGY AND MEDICAL
TECHNOLOGY CONFERENCE
May
23, 2008
CYPRESS BIOSCIENCE TO PRESENT AT FBR CAPITAL MARKETS SPRING INVESTOR CONFERENCE
May
19, 2008
CYPRESS BIOSCIENCE TO PRESENT AT CITI'S HEALTH CARE CONFERENCE
May
12, 2008
CYPRESS BIOSCIENCE ANNOUNCES FIRST QUARTER 2008 RESULTS
May
6, 2008
CYPRESS BIOSCIENCE TO PRESENT AT THE NEUROTECH INDUSTRY INVESTING & PARTNERING
CONFERENCE
May
1, 2008
CYPRESS BIOSCIENCE TO PRESENT AT DEUTSCHE BANK HEALTH CARE CONFERENCE
March
17, 2008
CYPRESS BIOSCIENCE ANNOUNCES FOURTH QUARTER AND FISCAL YEAR END 2007 RESULTS
March
14, 2008
CYPRESS BIOSCIENCE TO PRESENT AT COWEN & COMPANY 28TH ANNUAL HEALTH CARE
CONFERENCE
March
4, 2008
CYPRESS BIOSCIENCE CLOSES ACQUISITION OF PROPRIUS PHARMACEUTICALS
February
25, 2008
CYPRESS BIOSCIENCE TO ACQUIRE PROPRIUS PHARMACEUTICALS
February
21, 2008
FOREST AND CYPRESS ANNOUNCE FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR MILNACIPRAN
FOR THE TREATMENT OF FIBROMYALGIA
|
|

|